We would love to hear your thoughts about our site and services, please take our survey here.
Oh yeah well with cfd you can lose more than 100 lol. But as a shareholder your risk is 100% :P
Yeah who would have thought oil would go negative. Remember seeing so many posts "just buy the negative oil, take the cash and pump it back into the ground!" If only
I always invest large amounts spurs and of course sometimes I pick losers, so when my losers lose its a lot. But when my winners win it's a lot more.
Your maximum risk is always 100% so your maximum potential gains needs to be 100%+ otherwise why invest
Don't be upset by sirius, some lessons are expensive. I paid about £40k for my lesson on sirius
Yes it's true JHFH we need big pharma on our side. I would start to be worried if hemo tried to manufacture drugs on their own at this stage, would require huge capital input.
I like this model of discover then find a partner that hemo has. Low capital risk for hemo plus it's very nice to have the experience a big partner brings.
Refer back to sirius minerals for trying to raise huge capital and go it alone.
:) welcome
Hemo have a January to December financial year lunus
Very news rich indeed JHFH, also very nice to have a co-founder specializing in IP law.
Something has changed for the better, we have a new product candidate SAFE-HEMO-CAR-T. Expect in a month the RNS with successful in-vivo testing complete and inclusion under the PENN deal.
The MCAP remains the same but the long term potential continues to grow, there are huge intangible assets not yet priced into HEMO, and on commercial deal will gap up massively
Hello accountant,
The cash burn is normal for a pre-clinical pharma, the plan is to only be researching at this stage. There is the possibly to generate move revenues next year which would be very unusual for a pre-clinical company.
There is an RNS which states Global I for lupus and CDX is Eli Lilly. Vlad explained on the webinar that Lilly would have until ~1st December to come to an agreement on inlicensing CDX. CDX/covid/cart T news could all come before year end, plus other things.
The dilution statement doesn't cause me concern. If the Lilly deal goes through, any upfront payment will provide multiple years of research funding. If we get to next year and do need cash for something I wouldn't be against a placing if the price was reasonably high, I think hemo would do good stuff with extra money
The drug that kills Trump is worth X10 the drug that saves the world.
Me too Gell, let's meet up and roll around in our hemo shares!
Yes pawnking, people are on the hunt for the next micro cap covid pharma to blow up x10-20 in a month. If you missed out on nyct avct sng etc then just move on with your investing strat, get back to reality and stop dreaming.
The RNS said we're still on track*
I'm still holding, all in on hemo. The RNS Saturday we're still on track and I'm still confident.
Last year in October/November there were 3 RNS of hemo joining presentations, maybe these are yearly events? Also mid November last year we got an 'operational update' maybe that's coming too?
I'm prepared to wait for good things here, well passed the CDX agreement.
Only 1.5% of all shares traded today and we find ourselves back to the 10p consolidation point. To me this just people who bought a few days ago expecting news today getting out and they will be back in November.
Don't understand the hate for traders, just a very different tactics to investing. Anyone can buy and sell whenever they feel like.
Haaaaaah! Big Daddy's dangerous delicious double dipped dubious disaster loss...
Mjng, no I think before we only assumed there was no extension and we're in commercial discussions, because we didn't hear anything after the start of September elapsed. But now we heard it from the horses mouth.
But definitely I'm assuming the deal will be done and that's not 100% guarantee, but looking very likely. There is only 2 months left for Lilly to agree the deal, and we're still planned to reach the inflection point this year. Imo there is 80%+ the deal goes through by December, maybe even 90%+ chance.
For me, based on CDX alone this is a strong hold. Obviously lots of other pluses to hear about too.
Agree lunus, the wait continues as planned.
I disagree we good much more than nothing.
Confirmation that CDX is in commercial discussions along with reaffirmation that we're on track to reach the inflection point of Feldmans foresight.
Tells me keep holding and by year-end the Lilly deal will be done for sure.
No revenues, a bit disappointing but it's fine.
Cash position is strong, may require additional funding in 2021.
CDX is commercial discussions and on track to schedule completion (1st December).
Feldmann believes we will still reach inflection point in 2020.
All in all quite strong update albeit brief.